![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/05/2909021/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/06/26/2904574/0/en/Taysha-Gene-Therapies-Announces-Pricing-of-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
https://www.globenewswire.com/news-release/2024/06/25/2904183/0/en/Taysha-Gene-Therapies-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-positive-clinical-data-across
https://www.globenewswire.com/news-release/2024/06/12/2897431/0/en/Taysha-Gene-Therapies-to-Present-Clinical-Data-from-Both-REVEAL-Phase-1-2-Trials-During-Company-Hosted-Webcast-and-at-2024-IRSF-Rett-Syndrome-Scientific-Meeting.html
https://www.globenewswire.com/news-release/2024/06/07/2895320/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/14/2881832/0/en/Taysha-Gene-Therapies-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/07/2877209/0/en/Taysha-Gene-Therapies-to-Release-First-Quarter-2024-Financial-Results-and-Host-Conference-Call-and-Webcast-on-May-14.html
https://www.globenewswire.com/news-release/2024/05/03/2875350/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/02/2874163/0/en/Taysha-Gene-Therapies-Announces-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-Granted-by-U-S-FDA-for-TSHA-102-in-Rett-Syndrome.html